# 21 CFR 558.95 Bambermycins.

21 CFR 558.95 Bambermycins., “Bambermycins”, is a CFR section of [21 CFR Part 558, Subpart B—Specific New Animal Drugs for Use in Animal Feeds](https://ontology.bommaritollc.com/id/01a0f094-b654-744f-8805-7db7f398e9f2); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS](https://ontology.bommaritollc.com/id/01a0f094-b631-77c0-8360-43217423fdac) › [21 CFR Part 558—New animal drugs for use in animal feeds](https://ontology.bommaritollc.com/id/01a0f094-b879-70ea-b3b8-e26a66866044) › [21 CFR Part 558, Subpart B—Specific New Animal Drugs for Use in Animal Feeds](https://ontology.bommaritollc.com/id/01a0f094-b654-744f-8805-7db7f398e9f2)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 558.95](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35edbfe80664)
- `eli:cites`:
  - [21 CFR 510.455 Requirements for free-choice medicated feeds.](https://ontology.bommaritollc.com/id/01a0f094-c649-7209-95fc-5e33aab907b7)
  - [21 CFR 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications.](https://ontology.bommaritollc.com/id/01a0f094-c64a-701d-b272-158824f1f54d)
  - [21 CFR 556.75 Bambermycins.](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4)
  - [21 CFR 558.55 Amprolium.](https://ontology.bommaritollc.com/id/01a0f094-c9aa-735d-88e4-985f6b7515bb)
  - [21 CFR 558.58 Amprolium and ethopabate.](https://ontology.bommaritollc.com/id/01a0f094-c9ab-747e-9d9f-d05d7a88c699)
  - [21 CFR 558.95 Bambermycins.](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde)
  - [21 CFR 558.175 Clopidol.](https://ontology.bommaritollc.com/id/01a0f094-c9b2-771d-8778-969760a3d6a0)
  - [21 CFR 558.198 Dichlorvos.](https://ontology.bommaritollc.com/id/01a0f094-c9b4-7115-9bb1-2e82d2442c9a)
  - [21 CFR 558.265 Halofuginone.](https://ontology.bommaritollc.com/id/01a0f094-c9b9-7756-b6f1-c5feb57b7d32)
  - [21 CFR 558.311 Lasalocid.](https://ontology.bommaritollc.com/id/01a0f094-c9bd-750e-ac1d-93588af6f4b6)
  - [21 CFR 558.355 Monensin.](https://ontology.bommaritollc.com/id/01a0f094-c9c2-7602-a0ef-ed42ec9710cc)
  - [21 CFR 558.363 Narasin.](https://ontology.bommaritollc.com/id/01a0f094-c9c3-70bd-99ff-e939f6da9abf)
  - [21 CFR 558.364 Narasin and nicarbazin.](https://ontology.bommaritollc.com/id/01a0f094-c9c4-7074-81b5-05d4220447b1)
  - [21 CFR 558.366 Nicarbazin.](https://ontology.bommaritollc.com/id/01a0f094-c9c6-7586-bf63-158a164d56fd)
  - [21 CFR 558.550 Salinomycin.](https://ontology.bommaritollc.com/id/01a0f094-c9cd-77c2-a7e7-d3a5359a9ee1)
  - [21 CFR 558.680 Zoalene.](https://ontology.bommaritollc.com/id/01a0f094-c9d7-708f-a2d4-aede7cd17d48)
  - [21 CFR 573.920 Selenium.](https://ontology.bommaritollc.com/id/01a0f094-ca23-7607-bc4f-e0326e685b4b)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e1354b341d)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e43b-7303-b7d3-2693df159c72)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c79c-734f-bfe3-5fe5cd5344d2)
  - [evidence from https://www.govinfo.gov/link/cfr/21/558?sectionnum=95&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-6994-7502-9b60-554f9f4b38af)
- `schema:isPartOf`: [21 CFR Part 558, Subpart B—Specific New Animal Drugs for Use in Animal Feeds](https://ontology.bommaritollc.com/id/01a0f094-b654-744f-8805-7db7f398e9f2)
- `schema:legislationIdentifier`: 21 CFR 558.95
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Bambermycins
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/558?sectionnum=95&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/558?sectionnum=95&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 558.95 Bambermycins.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/558?sectionnum=95&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (1; `eli:cites`):
  - [21 CFR 556.75 Bambermycins.](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde)
Cite as: 21 CFR 558.95 Bambermycins.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
